Vara is focused on revolutionizing breast cancer screening by leveraging AI-assisted mammography to improve early detection rates and accessibility worldwide.

Founded as a spin-off from Merantix Venture Studio in 2018, Vara has partnered with leading screening centers in Germany and expanded internationally, including launch in Mexico, Greece, India, and Egypt. They hold CE and European MDR certifications for their software solutions while continuously contributing to clinical research validated by large prospective studies.